2018 Endocrine Board Review Course

Miami, FL US

Welcome to the Endocrine Board Review 2018 live course Evaluation

Unlike other board preparation meetings, the Endocrine Society's Board Review Course offers a comprehensive mock-exam format, with case-based ABIM-style questions forming the bulk of the presentations. Each section follows the ABIM blueprint for the board exam, covering the breadth and depth of the certification/recertification examination. But you won't just get a right or wrong answer—each case will be discussed in detail, with the correct and incorrect answer options reviewed. You'll also have opportunities to ask questions directly to the faculty, and review detailed answer explanations, references, and a customized score report.

Learning Objectives

Upon completion of this educational activity, learners will be able to demonstrate:

  • Enhanced medical knowledge and clinical skills across all major areas of endocrinology
  • Apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders
  • Successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 14.25 ABIM MOC
  • 14.25 AMA PRA Category 1 Credits
  • 14.25 CME Certificate of Participation
Course opens: 
Course expires: 

Day One – Tuesday, September 4, 2018

7:00–8:00 AMContinental Breakfast
8:00–8:15 AMWelcome and Overview of the Certification Process
Serge Jabbour, MD
8:15–10:00 AM

Diabetes Board Review - Part 1
Serge Jabbour, MD

10:15–11:45 AMAdrenal Board Review 
Richard Auchus, MD, PhD
12:45–2:30 PMCalcium and Bone Board Review
Carolyn Becker, MD
2:45–4:30 PMObesity/Lipids Board Review
Andrea Coviello, MD
4:30–4:45 PMWrap-up

Day Two – Wednesday, September 5, 2018

7:00–8:00 AMContinental Breakfast
8:00–9:30 AMPituitary Board Review
Laurence Katznelson, MD
9:30–9:45 AMBREAK
9:45–11:30 AMDiabetes Board Review - Part 2
Serge Jabbour, MD
11:30 AM–12:30 PMLUNCH
12:30–1:45 PMFemale Reproduction Board Review
Kathryn Martin, MD
1:45–3:00 PMMale Reproduction Board Review 
Frances Hayes, MD
3:00–3:15 PMBREAK
3:15–5:00 PMThyroid Board Review 
Elizabeth Pearce, MD
5:00–5:15 PMWrap-up
InterContinental Hotel Miami
100 Chopin Plaza
Room: Grand Ballroom
Miami, FL 33131
United States

Endocrine Board Review Chair
Serge A. Jabbour, MD – Thomas Jefferson University Sidney Kimmel Medical College

Faculty Authors
Richard J. Auchus, MD, PhD – University of Michigan
Carolyn B. Becker, MD – Brigham and Women’s Hospital
Andrea D. Coviello, MD – Duke University School of Medicine
Frances J. Hayes, MD – Massachusetts General Hospital
Laurence Katznelson, MD – Stanford University
Michelle F. Magee, MD – Georgetown University School of Medicine
Kathryn A. Martin, MD – Massachusetts General Hospital
Elizabeth N. Pearce, MD, MSc – Boston University School of Medicine

Medical Editor  
Abbie L. Young, MS, CGC, ELS(D)

Disclosure Policy

The faculty, committee members, and staff who are in a position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Richard J. Auchus, MD, PhD: Novartis Pharmaceuticals: Contracted Research Support & Consultant; Strongbridge Biopharma: Contracted Research Support & Consultant; Millendo Therapeutics: Consultant; Quest Diagnostics: Consultant; Corcept Therapeutics: Consultant; Janssen Pharmaceuticals: Consultant; Spruce Biosciences: Contracted Research Support and Consultant; Neurocrine Biosciences: Contracted Research Support; Diurnal, LTD: Contracted Research Support and Consultant; Viamet Pharmaceuticals: Consultant

Andrea D. Coviello, MD: Novo Nordisk Inc.: Consultant and Speaker

Serge A. Jabbour, MD: AstraZeneca, Eli Lilly & Janssen: Consultant/Advisory boards

Michelle F. Magee, MD: Lilly and Sanofi: Funding for conduct of research studies to the MedStar Health Research Institute; Sanofi: Speaker/Honoraria

The following faculty reported no relevant financial relationships: Carolyn B. Becker, MD; Frances J. Hayes, MD; Laurence Katznelson, MD; Kathryn A. Martin, MD; Elizabeth Pearce, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.


The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC):

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the responsibility of the Endocrine Society to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Verify Your ABIM MOC Eligibility

Log in then verify your profile details in the table below to confirm ABIM MOC eligibility.  If you see your name in the table below and other information is blank or incorrect, click the Review & Edit your Profile button to update and make changes.


My NameI am Certified by the ABIMMy ABIM NumberMy Date of Birth
[current-user:profile-profile:field-first-name] [current-user:profile-profile:field-last-name]




Review & Edit your Profile


Available Credit

  • 14.25 ABIM MOC
  • 14.25 AMA PRA Category 1 Credits
  • 14.25 CME Certificate of Participation

Click the Start button to go to the evaluation.